Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,392Revenue $M934Net Margin (%)15.3Z-Score1.7
Enterprise Value $M10,843EPS $2.2Operating Margin %29.1F-Score4
P/E(ttm))119Cash Flow Per Share $3.6Pre-tax Margin (%)22.7Higher ROA y-yN
Price/Book11.810-y EBITDA Growth Rate %0Quick Ratio2.2Cash flow > EarningsN
Price/Sales7.85-y EBITDA Growth Rate %0Current Ratio2.5Lower Leverage y-yN
Price/Cash Flow11.8y-y EBITDA Growth Rate %12.1ROA % (ttm)4.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)19.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M63.4ROI % (ttm)2.6Gross Margin Increase y-yN

Gurus Latest Trades with SLXP

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SLXPJoel Greenblatt 2014-03-31 Buy 0.48%$88.8 - $114.64
($101.95)
$ 132.3530%New holding, 307445 sh.307,445
SLXPJoel Greenblatt 2013-09-30 Sold Out -0.36%$65.73 - $75.54
($68.97)
$ 132.3592%Sold Out0
SLXPJoel Greenblatt 2013-06-30 Buy 0.36%$47.72 - $66.83
($57.19)
$ 132.35131%New holding, 127495 sh.127,495
SLXPVanguard Health Care Fund 2013-03-31 Add0.08%$40.472 - $51.37
($47.96)
$ 132.35176%Add 22.44%2,147,945
SLXPJoel Greenblatt 2013-03-31 Sold Out -0.15%$40.472 - $51.37
($47.96)
$ 132.35176%Sold Out0
SLXPJoel Greenblatt 2012-12-31 Add0.06%$37.97 - $42.9
($40.82)
$ 132.35224%Add 75.81%63,399
SLXPJoel Greenblatt 2012-09-30 Buy 0.1%$41.92 - $55.65
($47.44)
$ 132.35179%New holding, 36061 sh.36,061
SLXPVanguard Health Care Fund 2011-09-30 Add0.09%$26.18 - $40.9
($33.07)
$ 132.35300%Add 55.43%1,554,300
SLXPJohn Paulson 2011-09-30 Sold Out -0.2056%$26.18 - $40.9
($33.07)
$ 132.35300%Sold Out0
SLXPJohn Paulson 2011-06-30 Add0.19%$34.69 - $40.57
($37.85)
$ 132.35250%Add 971.43%1,500,000
SLXPGeorge Soros 2011-06-30 Sold Out $34.69 - $40.57
($37.85)
$ 132.35250%Sold Out0
SLXPJohn Paulson 2011-03-31 Buy 0.01%$31.61 - $48.03
($38.86)
$ 132.35241%New holding, 140000 sh.140,000
SLXPGeorge Soros 2011-03-31 Reduce$31.61 - $48.03
($38.86)
$ 132.35241%Reduce -95.44%5,700
SLXPVanguard Health Care Fund 2010-12-31 Buy 0.22%$35.96 - $48.61
($41.76)
$ 132.35217%New holding, 850000 sh.850,000
SLXPGeorge Soros 2010-12-31 Reduce-0.1%$35.96 - $48.61
($41.76)
$ 132.35217%Reduce -54.55%125,000
SLXPGeorge Soros 2010-09-30 Buy 0.16%$37.59 - $44.64
($41.19)
$ 132.35221%New holding, 275000 sh.275,000
SLXPGeorge Soros 2008-06-30 Sold Out -0.01%$6.25 - $7.68
($7)
$ 132.351791%Sold Out0
SLXPGeorge Soros 2007-12-31 Sold Out -0.01%$9.01 - $12.73
($11.4)
$ 132.351061%Sold Out0
SLXPGeorge Soros 2007-09-30 Buy 0.01%$10.97 - $13.32
($12.2)
$ 132.35985%New holding, 25320 sh.25,320
SLXPGeorge Soros 2006-12-31 Sold Out -0.02%$12.16 - $14.89
($13.6)
$ 132.35873%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SLXP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SLXP Joel Greenblatt 2014-03-31307,4450.480.48New Buy
SLXP Vanguard Health Care Fund 2014-03-312,032,8453.210.59-5.36%
Premium Most recent portfolio changes are included for Premium Members only!


SLXP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOGAN CAROLYN JPresident & CEO 2014-06-26Sell53,057$123.387.27view
Scruggs Rick DExecutive Vice President 2014-05-16Sell900$105.6725.25view
D ALONZO THOMASDirector 2014-04-22Sell11,530$110.8919.35view
Scruggs Rick DExecutive Vice President 2014-03-04Sell1,319$110.6619.6view
CHAPPELL JOHN FDirector 2014-03-04Sell10,000$112.217.96view
D ALONZO THOMASDirector 2014-01-10Sell12,050$91.8344.13view
DERBYSHIRE ADAM CEVP Finance/CFO 2014-01-09Sell30,001$91.4844.68view
Forbes William PEVP Research&Devel & CDO 2014-01-08Sell8,000$90.0646.96view
Scruggs Rick DExecutive Vice President 2014-01-07Sell8,463$88.3149.87view
KEANE WILLIAM PDirector 2014-01-07Sell22,500$88.3149.87view

Press Releases about SLXP :

Quarterly/Annual Reports about SLXP:

News about SLXP:

Articles On GuruFocus.com
Joel Greenblatt's Gotham Capital Top 5 New Stocks May 16 2014 
Weekly CFO Sells Highlight: FII, SLXP, CCK, VCI, WDC, STMP Dec 31 2012 
Weekly Guru Bargains Highlights: HMSY, FB, TSU, SLXP, ANR Oct 29 2012 
Value Shop Nuveen Investments Reports Second Quarter Portfolio Aug 19 2011 
Hedge Fund Giant John Paulson Reports Q2 Portfolio Aug 15 2011 
Salix Pharmaceuticals Ltd. (SLXP) President & CEO Carolyn J Logan sells 14,000 Shares Sep 23 2010 
Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C Derbyshire sells 5,000 Shares Dec 11 2009 
Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C Derbyshire sells 5,000 Shares Dec 02 2009 
Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C Derbyshire sells 5,000 Shares Nov 30 2009 
Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C Derbyshire sells 5,000 Shares Nov 19 2009 


More From Other Websites
[video] Faber Report: Inversion train rolling Jul 23 2014
An Inefficient Stock Market Will Catch Up To Progenics Jul 21 2014
INVESTOR ALERT – Salix Pharmaceuticals, Ltd.: The Law Offices of Vincent Wong Investigates the... Jul 21 2014
Salix-Pharming's Ruconest Gets FDA Nod for HAE Jul 18 2014
SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 17 2014
RBC Capital Markets Poaches M&A Health-Care Banker From Jefferies Jul 17 2014
Weakness Seen in Lannett Company (LCI): Stock Tumbles 17.1% Jul 17 2014
Salix, Pharming Group announces FDA approval of Ruconest Jul 17 2014
Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks... Jul 17 2014
Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks... Jul 17 2014
SALIX PHARMACEUTICALS LTD Files SEC form 8-K/A, Other Events, Financial Statements and Exhibits Jul 16 2014
Obama Inversion Crackdown Could Snag Pending Deals Jul 15 2014
SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 15 2014
Progenics-Salix Up on Encouraging Relistor News Jul 15 2014
Italian Ajani Emerges as Drug Billionaire in Switzerland Jul 15 2014
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Salix Pharmaceuticals, Ltd. and Its... Jul 15 2014
FDA Office of Drug Evaluation III Approves Salix's Request that the FDA Approve the RELISTOR®... Jul 14 2014
Midday movers: Citigroup, Newmont Mining & More Jul 14 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide